These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: Long term effectiveness of low dose mithramycin for Paget's disease of bone.
    Author: Russell AS, Chalmers IM, Percy JS, Lentle BC.
    Journal: Arthritis Rheum; 1979 Mar; 22(3):215-8. PubMed ID: 154331.
    Abstract:
    Nineteen patients with Paget's disease of bone were studied 7 months to 5 years after therapy with mithramycin in a dose averaging 11.5 microgram/kg body weight daily for 10 days. Thirteen patients, including 3 with the longest followup intervals, remained free of pain. Objective measures of disease activity (serum alkaline phosphatase level and 99mtechnetium pyrophosphate bone scan) were less favorable. There was no evidence of long term toxicity.
    [Abstract] [Full Text] [Related] [New Search]